Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo - Concepedia

Concepedia

Publication | Open Access

Voreloxin, a first-in-class anticancer quinolone derivative, acts synergistically with cytarabine in vitro and induces bone marrow aplasia in vivo

DOI Full Paper Access

47

Citations

21

References

2010

Year

Caroline D. Scatena, Jeffrey L. Kumer, Jennifer P. Arbitrario, Anthony R. Howlett, Rachael E. Hawtin, Judith A. Fox, Jeffrey A. Silverman

Cancer Chemotherapy and Pharmacology

Medicinal ChemistryFirst-in-class Anticancer QuinoloneMedicineMarrow AplasiaPharmacotherapyCell TransplantationMetronomic ChemotherapyAnti-cancer AgentPharmacologyRadiation OncologyTumor BiologyDrug Discovery

References

	Year	Citations

Page 1

Page 1